Aequus Pharmaceuticals (AQSZF)

[BioSpecialist]

New Email reply by Ceo .. This Stock has is now valued at ridiculous US$ 11 million which is a pure gift .
------


Company well financed and not needing capital;
2 press releases this month already regarding programs and opportunities in the medical cannabis space We have a number of product discussions underway and hope to have additional revenue generating assets for Canada to announce.

We expect at least 2 revenue product deals per year, similar to what we did last year We are waiting for Health Canada to send back the meeting minutes from our recent meeting. Expect to see progress and announcements on the Trokendi XR file once we receive the official minutes. As disappointing as the share price performance was last year we outperformed the majority of CDN specialty pharma companies.

The damage that Valeant and Concordia did to companies in our space was significant in 2016 and we suffered as well. I bought close to 1Million shares last year and look forward to adding more this year.

Best, Doug